SLC1A3 and glaucoma: We then examined if administration of BCAAs can prevent or delay retinal ganglion cell death in vivo. Glutamate-aspartate transporter (GLAST) knockout mice manifest chronic retinal ganglion cell loss and are used as a glaucoma model (Harada et al., 2007).